nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—F12—nipple—breast cancer	0.0224	0.0884	CbGeAlD
Ethanolamine Oleate—CYP2E1—Tamoxifen—breast cancer	0.0176	0.506	CbGbCtD
Ethanolamine Oleate—CYP2E1—Mitoxantrone—breast cancer	0.0172	0.494	CbGbCtD
Ethanolamine Oleate—FABP4—embryo—breast cancer	0.0147	0.058	CbGeAlD
Ethanolamine Oleate—FABP5—epithelium—breast cancer	0.0129	0.0506	CbGeAlD
Ethanolamine Oleate—F12—uterus—breast cancer	0.0125	0.0492	CbGeAlD
Ethanolamine Oleate—F12—pituitary gland—breast cancer	0.0123	0.0483	CbGeAlD
Ethanolamine Oleate—FABP5—skin of body—breast cancer	0.0122	0.0482	CbGeAlD
Ethanolamine Oleate—F12—adipose tissue—breast cancer	0.0122	0.0481	CbGeAlD
Ethanolamine Oleate—Varicose vein—Raloxifene—breast cancer	0.0116	0.0381	CcSEcCtD
Ethanolamine Oleate—FABP4—skin of body—breast cancer	0.0114	0.045	CbGeAlD
Ethanolamine Oleate—FABP5—uterus—breast cancer	0.0106	0.0418	CbGeAlD
Ethanolamine Oleate—F12—bone marrow—breast cancer	0.0106	0.0418	CbGeAlD
Ethanolamine Oleate—FABP5—adipose tissue—breast cancer	0.0104	0.0409	CbGeAlD
Ethanolamine Oleate—FABP4—adipose tissue—breast cancer	0.00971	0.0383	CbGeAlD
Ethanolamine Oleate—FABP5—female reproductive system—breast cancer	0.00955	0.0376	CbGeAlD
Ethanolamine Oleate—F12—endocrine gland—breast cancer	0.0095	0.0374	CbGeAlD
Ethanolamine Oleate—FABP5—adrenal gland—breast cancer	0.00932	0.0367	CbGeAlD
Ethanolamine Oleate—FABP4—female reproductive system—breast cancer	0.00893	0.0352	CbGeAlD
Ethanolamine Oleate—FABP4—adrenal gland—breast cancer	0.00871	0.0343	CbGeAlD
Ethanolamine Oleate—FABP5—female gonad—breast cancer	0.00869	0.0342	CbGeAlD
Ethanolamine Oleate—FABP4—bone marrow—breast cancer	0.00843	0.0332	CbGeAlD
Ethanolamine Oleate—FABP4—female gonad—breast cancer	0.00812	0.032	CbGeAlD
Ethanolamine Oleate—FABP5—endocrine gland—breast cancer	0.00808	0.0318	CbGeAlD
Ethanolamine Oleate—Varicose vein—Goserelin—breast cancer	0.00801	0.0262	CcSEcCtD
Ethanolamine Oleate—FABP4—endocrine gland—breast cancer	0.00756	0.0298	CbGeAlD
Ethanolamine Oleate—Pleural effusion—Letrozole—breast cancer	0.00596	0.0195	CcSEcCtD
Ethanolamine Oleate—FABP5—lymph node—breast cancer	0.00558	0.022	CbGeAlD
Ethanolamine Oleate—Necrosis—Idarubicin—breast cancer	0.00552	0.0181	CcSEcCtD
Ethanolamine Oleate—Dihomo-gamma-linolenic acid—FABP7—breast cancer	0.00542	0.254	CrCbGaD
Ethanolamine Oleate—Lacrimation increased—Ixabepilone—breast cancer	0.00526	0.0172	CcSEcCtD
Ethanolamine Oleate—FABP4—lymph node—breast cancer	0.00522	0.0206	CbGeAlD
Ethanolamine Oleate—Renal failure acute—Lapatinib—breast cancer	0.00506	0.0165	CcSEcCtD
Ethanolamine Oleate—Ulcer—Anastrozole—breast cancer	0.00483	0.0158	CcSEcCtD
Ethanolamine Oleate—Ulcer—Idarubicin—breast cancer	0.00458	0.015	CcSEcCtD
Ethanolamine Oleate—FABP5—Idarubicin—Epirubicin—breast cancer	0.00443	0.519	CbGdCrCtD
Ethanolamine Oleate—Oesophagitis—Ixabepilone—breast cancer	0.00443	0.0145	CcSEcCtD
Ethanolamine Oleate—Disseminated intravascular coagulation—Docetaxel—breast cancer	0.00427	0.014	CcSEcCtD
Ethanolamine Oleate—Orlistat—FASN—breast cancer	0.00423	0.199	CrCbGaD
Ethanolamine Oleate—Oesophageal ulcer—Docetaxel—breast cancer	0.00418	0.0137	CcSEcCtD
Ethanolamine Oleate—Alpha-Linolenic Acid—FABP7—breast cancer	0.00415	0.195	CrCbGaD
Ethanolamine Oleate—FABP5—Idarubicin—Doxorubicin—breast cancer	0.0041	0.481	CbGdCrCtD
Ethanolamine Oleate—Oesophageal ulcer—Capecitabine—breast cancer	0.00404	0.0132	CcSEcCtD
Ethanolamine Oleate—Varicose vein—Capecitabine—breast cancer	0.00396	0.013	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Idarubicin—breast cancer	0.00396	0.013	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Irinotecan—breast cancer	0.00375	0.0123	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Lapatinib—breast cancer	0.00362	0.0118	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Fluorouracil—breast cancer	0.00359	0.0117	CcSEcCtD
Ethanolamine Oleate—Necrosis—Vinorelbine—breast cancer	0.00341	0.0111	CcSEcCtD
Ethanolamine Oleate—Ulcer—Melphalan—breast cancer	0.00324	0.0106	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Fluoxymesterone—breast cancer	0.00323	0.0106	CcSEcCtD
Ethanolamine Oleate—Ulcer—Goserelin—breast cancer	0.00316	0.0103	CcSEcCtD
Ethanolamine Oleate—Alprostadil—PTGER1—breast cancer	0.00291	0.136	CrCbGaD
Ethanolamine Oleate—Oesophageal ulcer—Epirubicin—breast cancer	0.00282	0.00922	CcSEcCtD
Ethanolamine Oleate—Necrosis—Mitoxantrone—breast cancer	0.00281	0.00919	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Gemcitabine—breast cancer	0.0028	0.00917	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Chlorambucil—breast cancer	0.00276	0.00903	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Ixabepilone—breast cancer	0.00273	0.00893	CcSEcCtD
Ethanolamine Oleate—Necrosis—Fluorouracil—breast cancer	0.00269	0.0088	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Doxorubicin—breast cancer	0.00261	0.00853	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Docetaxel—breast cancer	0.00259	0.00848	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Epirubicin—breast cancer	0.00255	0.00835	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Vinorelbine—breast cancer	0.00244	0.00799	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Raloxifene—breast cancer	0.00244	0.00798	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Melphalan—breast cancer	0.00241	0.00787	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Irinotecan—breast cancer	0.00239	0.00783	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Doxorubicin—breast cancer	0.00236	0.00772	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Paclitaxel—breast cancer	0.00235	0.00768	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Thiotepa—breast cancer	0.00233	0.00763	CcSEcCtD
Ethanolamine Oleate—Ulcer—Mitoxantrone—breast cancer	0.00233	0.00762	CcSEcCtD
Ethanolamine Oleate—Ulcer—Irinotecan—breast cancer	0.00233	0.00762	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Lapatinib—breast cancer	0.0023	0.00751	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Fluorouracil—breast cancer	0.00229	0.0075	CcSEcCtD
Ethanolamine Oleate—Necrosis—Paclitaxel—breast cancer	0.00229	0.00749	CcSEcCtD
Ethanolamine Oleate—Ulcer—Gemcitabine—breast cancer	0.00227	0.00743	CcSEcCtD
Ethanolamine Oleate—Ulcer—Fluorouracil—breast cancer	0.00223	0.0073	CcSEcCtD
Ethanolamine Oleate—Chest pain—Fulvestrant—breast cancer	0.0022	0.0072	CcSEcCtD
Ethanolamine Oleate—Chest pain—Toremifene—breast cancer	0.00217	0.00711	CcSEcCtD
Ethanolamine Oleate—Orlistat—PLA2G4A—breast cancer	0.00216	0.101	CrCbGaD
Ethanolamine Oleate—Pain—Carboplatin—breast cancer	0.00208	0.00681	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Docetaxel—breast cancer	0.00199	0.00651	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Chlorambucil—breast cancer	0.00198	0.00646	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Paclitaxel—breast cancer	0.00195	0.00638	CcSEcCtD
Ethanolamine Oleate—Necrosis—Docetaxel—breast cancer	0.00194	0.00635	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Fluorouracil—breast cancer	0.00193	0.00631	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Capecitabine—breast cancer	0.00193	0.0063	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Carboplatin—breast cancer	0.00193	0.0063	CcSEcCtD
Ethanolamine Oleate—Chest pain—Exemestane—breast cancer	0.00191	0.00626	CcSEcCtD
Ethanolamine Oleate—Pain—Fulvestrant—breast cancer	0.00181	0.00591	CcSEcCtD
Ethanolamine Oleate—Chest pain—Ixabepilone—breast cancer	0.00181	0.0059	CcSEcCtD
Ethanolamine Oleate—Pain—Toremifene—breast cancer	0.00178	0.00583	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Tamoxifen—breast cancer	0.00176	0.00575	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Epirubicin—breast cancer	0.00175	0.00572	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Irinotecan—breast cancer	0.00173	0.00567	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Mitoxantrone—breast cancer	0.00173	0.00567	CcSEcCtD
Ethanolamine Oleate—Chest pain—Letrozole—breast cancer	0.0017	0.00556	CcSEcCtD
Ethanolamine Oleate—Chest pain—Anastrozole—breast cancer	0.0017	0.00556	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Goserelin—breast cancer	0.00168	0.00549	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Fulvestrant—breast cancer	0.00167	0.00546	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Docetaxel—breast cancer	0.00165	0.00541	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Paclitaxel—breast cancer	0.00164	0.00537	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Anastrozole—breast cancer	0.00163	0.00533	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Letrozole—breast cancer	0.00163	0.00533	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Doxorubicin—breast cancer	0.00162	0.00529	CcSEcCtD
Ethanolamine Oleate—Chest pain—Idarubicin—breast cancer	0.00161	0.00528	CcSEcCtD
Ethanolamine Oleate—Chest pain—Raloxifene—breast cancer	0.00161	0.00528	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Capecitabine—breast cancer	0.0016	0.00524	CcSEcCtD
Ethanolamine Oleate—Pain—Exemestane—breast cancer	0.00157	0.00513	CcSEcCtD
Ethanolamine Oleate—Ulcer—Capecitabine—breast cancer	0.00156	0.0051	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Idarubicin—breast cancer	0.00155	0.00506	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Vinorelbine—breast cancer	0.0015	0.00492	CcSEcCtD
Ethanolamine Oleate—Pain—Ixabepilone—breast cancer	0.00148	0.00484	CcSEcCtD
Ethanolamine Oleate—CYP2E1—female reproductive system—breast cancer	0.00146	0.00576	CbGeAlD
Ethanolamine Oleate—Body temperature increased—Exemestane—breast cancer	0.00145	0.00474	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Thiotepa—breast cancer	0.00144	0.0047	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Methotrexate—breast cancer	0.00143	0.00469	CcSEcCtD
Ethanolamine Oleate—CYP2E1—adrenal gland—breast cancer	0.00143	0.00562	CbGeAlD
Ethanolamine Oleate—Renal failure acute—Paclitaxel—breast cancer	0.00141	0.00462	CcSEcCtD
Ethanolamine Oleate—Necrosis—Methotrexate—breast cancer	0.0014	0.00458	CcSEcCtD
Ethanolamine Oleate—Pain—Anastrozole—breast cancer	0.00139	0.00456	CcSEcCtD
Ethanolamine Oleate—Pain—Letrozole—breast cancer	0.00139	0.00456	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Docetaxel—breast cancer	0.00139	0.00456	CcSEcCtD
Ethanolamine Oleate—Abscess—Methotrexate—breast cancer	0.00139	0.00454	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Ixabepilone—breast cancer	0.00137	0.00447	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Capecitabine—breast cancer	0.00135	0.00441	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Epirubicin—breast cancer	0.00134	0.00439	CcSEcCtD
Ethanolamine Oleate—Pain—Raloxifene—breast cancer	0.00132	0.00433	CcSEcCtD
Ethanolamine Oleate—Necrosis—Epirubicin—breast cancer	0.00131	0.00428	CcSEcCtD
Ethanolamine Oleate—Abscess—Epirubicin—breast cancer	0.0013	0.00425	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Anastrozole—breast cancer	0.00129	0.00421	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Letrozole—breast cancer	0.00129	0.00421	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Doxorubicin—breast cancer	0.00124	0.00406	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Irinotecan—breast cancer	0.00124	0.00406	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Mitoxantrone—breast cancer	0.00124	0.00406	CcSEcCtD
Ethanolamine Oleate—CYP2E1—endocrine gland—breast cancer	0.00124	0.00487	CbGeAlD
Ethanolamine Oleate—Body temperature increased—Raloxifene—breast cancer	0.00122	0.004	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Idarubicin—breast cancer	0.00122	0.004	CcSEcCtD
Ethanolamine Oleate—Necrosis—Doxorubicin—breast cancer	0.00121	0.00396	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Gemcitabine—breast cancer	0.00121	0.00395	CcSEcCtD
Ethanolamine Oleate—Abscess—Doxorubicin—breast cancer	0.0012	0.00393	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Fluorouracil—breast cancer	0.00119	0.00389	CcSEcCtD
Ethanolamine Oleate—Chest pain—Tamoxifen—breast cancer	0.00116	0.0038	CcSEcCtD
Ethanolamine Oleate—Ulcer—Methotrexate—breast cancer	0.00116	0.0038	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Capecitabine—breast cancer	0.00116	0.0038	CcSEcCtD
Ethanolamine Oleate—Chest pain—Melphalan—breast cancer	0.00114	0.00373	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Epirubicin—breast cancer	0.00112	0.00365	CcSEcCtD
Ethanolamine Oleate—Chest pain—Goserelin—breast cancer	0.00111	0.00363	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Melphalan—breast cancer	0.00109	0.00357	CcSEcCtD
Ethanolamine Oleate—Ulcer—Epirubicin—breast cancer	0.00109	0.00356	CcSEcCtD
Ethanolamine Oleate—Pain—Chlorambucil—breast cancer	0.00107	0.0035	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Goserelin—breast cancer	0.00107	0.00348	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Doxorubicin—breast cancer	0.00103	0.00338	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Paclitaxel—breast cancer	0.00101	0.00331	CcSEcCtD
Ethanolamine Oleate—Ulcer—Doxorubicin—breast cancer	0.00101	0.00329	CcSEcCtD
Ethanolamine Oleate—Chest pain—Vinorelbine—breast cancer	0.000995	0.00325	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Chlorambucil—breast cancer	0.00099	0.00324	CcSEcCtD
Ethanolamine Oleate—Pain—Vinblastine—breast cancer	0.000982	0.00321	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Vinorelbine—breast cancer	0.000954	0.00312	CcSEcCtD
Ethanolamine Oleate—Pain—Tamoxifen—breast cancer	0.000954	0.00312	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Epirubicin—breast cancer	0.000939	0.00307	CcSEcCtD
Ethanolamine Oleate—Pain—Melphalan—breast cancer	0.000934	0.00305	CcSEcCtD
Ethanolamine Oleate—Pain—Goserelin—breast cancer	0.000911	0.00298	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Doxorubicin—breast cancer	0.000869	0.00284	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Methotrexate—breast cancer	0.000864	0.00283	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Docetaxel—breast cancer	0.000858	0.00281	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Goserelin—breast cancer	0.000842	0.00275	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Capecitabine—breast cancer	0.00083	0.00272	CcSEcCtD
Ethanolamine Oleate—Chest pain—Mitoxantrone—breast cancer	0.000821	0.00268	CcSEcCtD
Ethanolamine Oleate—Dihomo-gamma-linolenic acid—PTGS1—breast cancer	0.000821	0.0385	CrCbGaD
Ethanolamine Oleate—Pain—Vinorelbine—breast cancer	0.000816	0.00267	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Epirubicin—breast cancer	0.000808	0.00264	CcSEcCtD
Ethanolamine Oleate—Chest pain—Gemcitabine—breast cancer	0.000799	0.00261	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Irinotecan—breast cancer	0.000787	0.00257	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Mitoxantrone—breast cancer	0.000787	0.00257	CcSEcCtD
Ethanolamine Oleate—Chest pain—Fluorouracil—breast cancer	0.000786	0.00257	CcSEcCtD
Ethanolamine Oleate—Pain—Thiotepa—breast cancer	0.000779	0.00255	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Gemcitabine—breast cancer	0.000766	0.00251	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Vinorelbine—breast cancer	0.000754	0.00247	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Fluorouracil—breast cancer	0.000753	0.00246	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Doxorubicin—breast cancer	0.000748	0.00245	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Thiotepa—breast cancer	0.00072	0.00236	CcSEcCtD
Ethanolamine Oleate—Sodium lauryl sulfate—ALB—breast cancer	0.000698	0.0327	CrCbGaD
Ethanolamine Oleate—Pain—Mitoxantrone—breast cancer	0.000673	0.0022	CcSEcCtD
Ethanolamine Oleate—Pain—Irinotecan—breast cancer	0.000673	0.0022	CcSEcCtD
Ethanolamine Oleate—Chest pain—Paclitaxel—breast cancer	0.000669	0.00219	CcSEcCtD
Ethanolamine Oleate—Pain—Gemcitabine—breast cancer	0.000655	0.00214	CcSEcCtD
Ethanolamine Oleate—Pain—Fluorouracil—breast cancer	0.000644	0.00211	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Paclitaxel—breast cancer	0.000642	0.0021	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Mitoxantrone—breast cancer	0.000622	0.00203	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Irinotecan—breast cancer	0.000622	0.00203	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Methotrexate—breast cancer	0.000618	0.00202	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Gemcitabine—breast cancer	0.000606	0.00198	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Fluorouracil—breast cancer	0.000596	0.00195	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Epirubicin—breast cancer	0.000578	0.00189	CcSEcCtD
Ethanolamine Oleate—Chest pain—Docetaxel—breast cancer	0.000567	0.00186	CcSEcCtD
Ethanolamine Oleate—Chest pain—Capecitabine—breast cancer	0.000549	0.0018	CcSEcCtD
Ethanolamine Oleate—Pain—Paclitaxel—breast cancer	0.000549	0.00179	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Docetaxel—breast cancer	0.000544	0.00178	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Doxorubicin—breast cancer	0.000535	0.00175	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Paclitaxel—breast cancer	0.000507	0.00166	CcSEcCtD
Ethanolamine Oleate—Dihomo-gamma-linolenic acid—PTGS2—breast cancer	0.000469	0.022	CrCbGaD
Ethanolamine Oleate—Pain—Docetaxel—breast cancer	0.000465	0.00152	CcSEcCtD
Ethanolamine Oleate—Orlistat—CYP3A4—breast cancer	0.000459	0.0215	CrCbGaD
Ethanolamine Oleate—Pain—Capecitabine—breast cancer	0.00045	0.00147	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Docetaxel—breast cancer	0.00043	0.00141	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Capecitabine—breast cancer	0.000416	0.00136	CcSEcCtD
Ethanolamine Oleate—Chest pain—Methotrexate—breast cancer	0.000409	0.00134	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Methotrexate—breast cancer	0.000392	0.00128	CcSEcCtD
Ethanolamine Oleate—Chest pain—Epirubicin—breast cancer	0.000383	0.00125	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—SULT1A1—breast cancer	0.000377	0.001	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PIK3CG—breast cancer	0.000377	0.001	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—EGF—breast cancer	0.000372	0.000991	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—LEP—breast cancer	0.000372	0.00099	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—IDH1—breast cancer	0.000368	0.00098	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GSTA1—breast cancer	0.000368	0.00098	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Epirubicin—breast cancer	0.000367	0.0012	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—KDR—breast cancer	0.000364	0.00097	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NAT2—breast cancer	0.000364	0.000969	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CDK4—breast cancer	0.000357	0.000949	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—MET—breast cancer	0.000357	0.000949	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Doxorubicin—breast cancer	0.000354	0.00116	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—IGF1—breast cancer	0.000345	0.000918	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—AKT2—breast cancer	0.000345	0.000917	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—NOTCH1—breast cancer	0.000343	0.000913	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—breast cancer	0.000342	0.00091	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Doxorubicin—breast cancer	0.000339	0.00111	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—breast cancer	0.000338	0.000898	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	0.000336	0.000895	CbGpPWpGaD
Ethanolamine Oleate—Pain—Methotrexate—breast cancer	0.000335	0.0011	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP1B1—breast cancer	0.000332	0.000883	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PIK3CD—breast cancer	0.000331	0.000881	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CAV1—breast cancer	0.000329	0.000876	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—SERPINE1—breast cancer	0.000328	0.000872	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—ALB—breast cancer	0.000327	0.00087	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	0.000324	0.000862	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	0.000321	0.000854	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	0.000321	0.000853	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—DPYD—breast cancer	0.000319	0.000849	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—MED12—breast cancer	0.000319	0.000849	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	0.000316	0.000841	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—CYP1A1—breast cancer	0.000315	0.000839	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	0.000314	0.000837	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ALDOA—breast cancer	0.000314	0.000836	CbGpPWpGaD
Ethanolamine Oleate—Pain—Epirubicin—breast cancer	0.000314	0.00103	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—NOS3—breast cancer	0.000313	0.000832	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—breast cancer	0.000312	0.00083	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Methotrexate—breast cancer	0.00031	0.00101	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Biological oxidations—ALDH1A1—breast cancer	0.000309	0.000823	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	0.000309	0.000821	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—AKT2—breast cancer	0.000307	0.000817	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NCOA3—breast cancer	0.000305	0.000812	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLC2A2—breast cancer	0.000303	0.000806	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	0.0003	0.000798	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—MMP2—breast cancer	0.000297	0.000792	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ABCG2—breast cancer	0.000297	0.00079	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CPT1A—breast cancer	0.000297	0.00079	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—MTR—breast cancer	0.000297	0.00079	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—RAF1—breast cancer	0.000296	0.000787	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HPGDS—breast cancer	0.000291	0.000774	CbGpPWpGaD
Ethanolamine Oleate—Pain—Doxorubicin—breast cancer	0.00029	0.000949	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Epirubicin—breast cancer	0.00029	0.000948	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—HBA1—breast cancer	0.000289	0.00077	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PIK3CB—breast cancer	0.000289	0.000768	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GSTT1—breast cancer	0.000282	0.000751	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ACHE—breast cancer	0.000282	0.000751	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—breast cancer	0.000277	0.000738	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTA3—breast cancer	0.000276	0.000734	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	0.000273	0.000725	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTA3—breast cancer	0.000272	0.000723	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Doxorubicin—breast cancer	0.000268	0.000878	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—CYP17A1—breast cancer	0.000267	0.000711	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—IL2—breast cancer	0.000265	0.000705	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ENO1—breast cancer	0.000265	0.000704	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTGS1—breast cancer	0.000265	0.000704	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	0.000264	0.000701	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—RAF1—breast cancer	0.000263	0.000701	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—RELA—breast cancer	0.000262	0.000698	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—ERBB2—breast cancer	0.000261	0.000694	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—ALB—breast cancer	0.00026	0.000692	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	0.00026	0.000692	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP2D6—breast cancer	0.000259	0.00069	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	0.000256	0.000682	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	0.000255	0.000678	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NCOA2—breast cancer	0.000255	0.000678	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTA4—breast cancer	0.000252	0.000671	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—breast cancer	0.000252	0.000669	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTA4—breast cancer	0.000249	0.000662	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—FASN—breast cancer	0.000247	0.000657	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—BCHE—breast cancer	0.000246	0.000654	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTA2—breast cancer	0.000246	0.000654	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLC5A5—breast cancer	0.000243	0.000646	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—SULT1A1—breast cancer	0.000243	0.000646	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GPX2—breast cancer	0.000242	0.000645	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—SULT1A1—breast cancer	0.000239	0.000637	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GPX4—breast cancer	0.000239	0.000637	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTA1—breast cancer	0.000237	0.000631	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NQO1—breast cancer	0.000235	0.000624	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—SLC2A1—breast cancer	0.000235	0.000624	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—NAT2—breast cancer	0.000234	0.000624	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—SRC—breast cancer	0.000231	0.000616	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—NAT2—breast cancer	0.000231	0.000615	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	0.00023	0.000611	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP3A4—breast cancer	0.000229	0.000609	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CTNNB1—breast cancer	0.000228	0.000607	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	0.000228	0.000606	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—VEGFA—breast cancer	0.000225	0.0006	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP1B1—breast cancer	0.000225	0.000598	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—MMP9—breast cancer	0.000224	0.000595	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HSP90AA1—breast cancer	0.000221	0.000587	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NCOA1—breast cancer	0.000215	0.000571	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—MAPK3—breast cancer	0.000213	0.000567	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—STK11—breast cancer	0.000211	0.000563	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP19A1—breast cancer	0.000211	0.000563	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—TGFB1—breast cancer	0.000207	0.00055	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	0.000207	0.00055	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SRC—breast cancer	0.000206	0.000548	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—VEGFA—breast cancer	0.000201	0.000534	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—STAT3—breast cancer	0.000199	0.000529	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PTEN—breast cancer	0.000199	0.000528	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—COMT—breast cancer	0.000197	0.000523	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GSTP1—breast cancer	0.000196	0.000521	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Tryptophan metabolism—MDM2—breast cancer	0.000194	0.000517	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HMOX1—breast cancer	0.000193	0.000513	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ITPR1—breast cancer	0.000193	0.000512	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—KRAS—breast cancer	0.000192	0.00051	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—MTR—breast cancer	0.000191	0.000508	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—MAPK3—breast cancer	0.00019	0.000505	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—HPGDS—breast cancer	0.000187	0.000499	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ABCB1—breast cancer	0.000185	0.000493	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—TGFB1—breast cancer	0.000184	0.00049	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TYMS—breast cancer	0.000182	0.000484	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTT1—breast cancer	0.000182	0.000484	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—EGFR—breast cancer	0.000181	0.000481	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PLA2G4A—breast cancer	0.00018	0.000478	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GSTM1—breast cancer	0.00018	0.000478	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NCOR1—breast cancer	0.00018	0.000478	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—PIK3CA—breast cancer	0.000176	0.000468	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GPX1—breast cancer	0.000172	0.000458	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—TNF—breast cancer	0.000172	0.000458	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP17A1—breast cancer	0.000172	0.000458	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—KRAS—breast cancer	0.000171	0.000454	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CYP1A1—breast cancer	0.00017	0.000454	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—PTGS1—breast cancer	0.00017	0.000453	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—TP53—breast cancer	0.00017	0.000453	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP17A1—breast cancer	0.00017	0.000452	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ERCC2—breast cancer	0.000169	0.00045	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP2D6—breast cancer	0.000167	0.000444	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP2D6—breast cancer	0.000165	0.000438	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—NCOA2—breast cancer	0.000164	0.000436	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—HRAS—breast cancer	0.000163	0.000433	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—MTHFR—breast cancer	0.000159	0.000423	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP3A4—breast cancer	0.000147	0.000392	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CAV1—breast cancer	0.000147	0.00039	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP3A4—breast cancer	0.000145	0.000387	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—HRAS—breast cancer	0.000145	0.000386	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP1B1—breast cancer	0.000145	0.000385	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—AKT1—breast cancer	0.000144	0.000383	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP1B1—breast cancer	0.000143	0.00038	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	0.00014	0.000373	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—IL6—breast cancer	0.000139	0.000369	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—NCOA1—breast cancer	0.000138	0.000368	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP19A1—breast cancer	0.000136	0.000362	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP19A1—breast cancer	0.000134	0.000357	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PIK3CG—breast cancer	0.000134	0.000355	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—AKT1—breast cancer	0.000128	0.000341	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—COMT—breast cancer	0.000127	0.000337	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTP1—breast cancer	0.000126	0.000335	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—COMT—breast cancer	0.000125	0.000332	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTP1—breast cancer	0.000124	0.000331	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PIK3CD—breast cancer	0.000117	0.000312	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ALB—breast cancer	0.000116	0.000308	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTM1—breast cancer	0.000116	0.000308	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTM1—breast cancer	0.000114	0.000304	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NOS3—breast cancer	0.000111	0.000295	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP1A1—breast cancer	0.00011	0.000292	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP1A1—breast cancer	0.000108	0.000288	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PIK3CB—breast cancer	0.000102	0.000272	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTGS2—breast cancer	0.000101	0.00027	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTEN—breast cancer	8.84e-05	0.000235	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SYNJ2—breast cancer	8.83e-05	0.000235	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NDUFS3—breast cancer	8.21e-05	0.000218	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CHST9—breast cancer	7.72e-05	0.000205	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—COX11—breast cancer	7.32e-05	0.000195	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CDA—breast cancer	6.69e-05	0.000178	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SHMT1—breast cancer	6.69e-05	0.000178	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC2A5—breast cancer	6.44e-05	0.000171	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLCO1B1—breast cancer	6.44e-05	0.000171	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PIK3CA—breast cancer	6.24e-05	0.000166	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—APRT—breast cancer	6.22e-05	0.000166	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ANGPTL4—breast cancer	5.85e-05	0.000156	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ESRRA—breast cancer	5.85e-05	0.000156	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HADHB—breast cancer	5.54e-05	0.000148	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GPI—breast cancer	5.54e-05	0.000148	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ALDH7A1—breast cancer	5.29e-05	0.000141	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ALDH1A1—breast cancer	5.29e-05	0.000141	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AKT1—breast cancer	5.1e-05	0.000136	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—FHL2—breast cancer	5.07e-05	0.000135	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PHGDH—breast cancer	5.07e-05	0.000135	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NME1—breast cancer	5.07e-05	0.000135	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ADSL—breast cancer	5.07e-05	0.000135	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—UMPS—breast cancer	5.07e-05	0.000135	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HPSE—breast cancer	4.97e-05	0.000132	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—BRIP1—breast cancer	4.97e-05	0.000132	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—LDHB—breast cancer	4.97e-05	0.000132	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTA3—breast cancer	4.71e-05	0.000125	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HMMR—breast cancer	4.71e-05	0.000125	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ABCC1—breast cancer	4.71e-05	0.000125	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PPARGC1B—breast cancer	4.57e-05	0.000121	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CA9—breast cancer	4.31e-05	0.000115	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTA4—breast cancer	4.31e-05	0.000115	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTA2—breast cancer	4.2e-05	0.000112	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GPX2—breast cancer	4.2e-05	0.000112	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GPX4—breast cancer	4.15e-05	0.00011	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SULT1A1—breast cancer	4.15e-05	0.00011	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—IDH1—breast cancer	4.05e-05	0.000108	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTA1—breast cancer	4.05e-05	0.000108	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NAT2—breast cancer	4.01e-05	0.000107	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—MED12—breast cancer	3.52e-05	9.35e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—DPYD—breast cancer	3.52e-05	9.35e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ALDOA—breast cancer	3.46e-05	9.21e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NCOA3—breast cancer	3.36e-05	8.94e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC2A2—breast cancer	3.34e-05	8.88e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CPT1A—breast cancer	3.27e-05	8.7e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—MTR—breast cancer	3.27e-05	8.7e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ABCG2—breast cancer	3.27e-05	8.7e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HPGDS—breast cancer	3.2e-05	8.53e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HBA1—breast cancer	3.18e-05	8.47e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ACHE—breast cancer	3.11e-05	8.27e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTT1—breast cancer	3.11e-05	8.27e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP17A1—breast cancer	2.94e-05	7.83e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ENO1—breast cancer	2.91e-05	7.75e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTGS1—breast cancer	2.91e-05	7.75e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP2D6—breast cancer	2.86e-05	7.6e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NCOA2—breast cancer	2.8e-05	7.46e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—FASN—breast cancer	2.72e-05	7.24e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—BCHE—breast cancer	2.71e-05	7.21e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC5A5—breast cancer	2.67e-05	7.12e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC2A1—breast cancer	2.58e-05	6.87e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NQO1—breast cancer	2.58e-05	6.87e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP3A4—breast cancer	2.52e-05	6.7e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP1B1—breast cancer	2.48e-05	6.59e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HSP90AA1—breast cancer	2.43e-05	6.46e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NCOA1—breast cancer	2.36e-05	6.29e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP19A1—breast cancer	2.33e-05	6.2e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—STK11—breast cancer	2.33e-05	6.2e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—COMT—breast cancer	2.16e-05	5.76e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTP1—breast cancer	2.15e-05	5.73e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HMOX1—breast cancer	2.12e-05	5.65e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ITPR1—breast cancer	2.12e-05	5.64e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ABCB1—breast cancer	2.04e-05	5.43e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TYMS—breast cancer	2e-05	5.33e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTM1—breast cancer	1.98e-05	5.27e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NCOR1—breast cancer	1.98e-05	5.27e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PLA2G4A—breast cancer	1.98e-05	5.27e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GPX1—breast cancer	1.9e-05	5.05e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP1A1—breast cancer	1.88e-05	4.99e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ERCC2—breast cancer	1.86e-05	4.95e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—MTHFR—breast cancer	1.75e-05	4.66e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CAV1—breast cancer	1.61e-05	4.29e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PIK3CG—breast cancer	1.47e-05	3.91e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PIK3CD—breast cancer	1.29e-05	3.44e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ALB—breast cancer	1.28e-05	3.39e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NOS3—breast cancer	1.22e-05	3.25e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PIK3CB—breast cancer	1.13e-05	3e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTGS2—breast cancer	1.12e-05	2.97e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTEN—breast cancer	9.73e-06	2.59e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PIK3CA—breast cancer	6.87e-06	1.83e-05	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AKT1—breast cancer	5.61e-06	1.49e-05	CbGpPWpGaD
